Trupanion (NASDAQ:TRUP) Hits New 52-Week Low – Time to Sell?
by Renee Jackson · The Cerbat GemTrupanion, Inc. (NASDAQ:TRUP – Get Free Report)’s stock price reached a new 52-week low on Tuesday . The company traded as low as $30.85 and last traded at $31.22, with a volume of 608287 shares changing hands. The stock had previously closed at $32.44.
Analyst Upgrades and Downgrades
Several analysts have recently commented on the stock. Weiss Ratings restated a “sell (d+)” rating on shares of Trupanion in a research note on Monday, December 29th. Cantor Fitzgerald reduced their price objective on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a research report on Wednesday, January 14th. Zacks Research raised Trupanion from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 6th. Piper Sandler reduced their price target on Trupanion from $67.00 to $60.00 and set an “overweight” rating for the company in a report on Friday, December 19th. Finally, Stifel Nicolaus reduced their price target on shares of Trupanion from $45.00 to $42.00 and set a “hold” rating for the company in a research report on Tuesday, November 18th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $51.00.
Check Out Our Latest Stock Analysis on TRUP
Trupanion Stock Performance
The stock’s fifty day simple moving average is $36.35 and its two-hundred day simple moving average is $42.30. The company has a market cap of $1.35 billion, a price-to-earnings ratio of 86.72 and a beta of 1.58. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.71 and a current ratio of 1.71.
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its quarterly earnings results on Thursday, November 6th. The financial services provider reported $0.13 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.76). Trupanion had a net margin of 1.10% and a return on equity of 4.48%. The business had revenue of $366.92 million during the quarter, compared to analysts’ expectations of $361.58 million. During the same quarter in the previous year, the business posted $0.03 EPS. The company’s quarterly revenue was up 12.0% on a year-over-year basis. Equities research analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current year.
Insider Buying and Selling
In other Trupanion news, CFO Fawwad Qureshi sold 6,202 shares of the company’s stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $35.45, for a total value of $219,860.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO John R. Gallagher sold 6,383 shares of Trupanion stock in a transaction that occurred on Friday, November 28th. The shares were sold at an average price of $34.82, for a total transaction of $222,256.06. Following the sale, the chief operating officer owned 32,721 shares in the company, valued at $1,139,345.22. This represents a 16.32% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 41,307 shares of company stock valued at $1,556,742. Corporate insiders own 5.42% of the company’s stock.
Hedge Funds Weigh In On Trupanion
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Campbell & CO Investment Adviser LLC acquired a new stake in shares of Trupanion in the 3rd quarter valued at about $3,772,000. JPMorgan Chase & Co. increased its holdings in Trupanion by 66.7% in the second quarter. JPMorgan Chase & Co. now owns 161,781 shares of the financial services provider’s stock valued at $8,955,000 after buying an additional 64,704 shares during the last quarter. Kopion Asset Management LLC raised its stake in Trupanion by 20.8% during the third quarter. Kopion Asset Management LLC now owns 264,603 shares of the financial services provider’s stock valued at $11,452,000 after buying an additional 45,594 shares in the last quarter. Fox Run Management L.L.C. bought a new position in Trupanion during the 2nd quarter worth approximately $612,000. Finally, Texas Permanent School Fund Corp grew its position in shares of Trupanion by 111.7% in the 2nd quarter. Texas Permanent School Fund Corp now owns 63,468 shares of the financial services provider’s stock worth $3,513,000 after acquiring an additional 33,483 shares in the last quarter.
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.